OTC vs Prescription Medicines: How Decisions Are Made and Why They Differ Globally

When you walk into a pharmacy, some aisles are open for browsing, while other medicines remain locked away or require a formal authorisation. This distinction separates over-the-counter (OTC) medicines from prescription-only medicines. An OTC medicine is one that can generally be purchased directly by a consumer, because it is considered safe for use without the direct supervision of a healthcare professional. A prescription-only medicine, by contrast, can only be dispensed by a pharmacist after a qualified clinician has assessed the patient and authorised the treatment. However, the line between these two categories is not fixed, nor is it universally identical. A medicine available off the shelf in one country might require a prescription in another, depending on local health regulations and how risk is evaluated.

The classification of a medicine is determined by national regulatory authorities. These agencies assess the safety profile of a drug, the severity of the condition it treats, and the likelihood that a consumer can accurately self-diagnose their ailment. As medical knowledge evolves and real-world safety data accumulates, regulators routinely re-evaluate these classifications, leading to a formal process known as a prescription-to-OTC switch.

The Rx-to-OTC Switch Process

Most new medicines enter the market as prescription-only. This is the most cautious approach, as new drugs often treat complex conditions, carry a higher potential for severe side effects, or require precise dosing tailored to an individual patient. However, after a medicine has been on the market for several years and has been used by millions of people, its safety profile becomes well-established. Pharmaceutical companies may then apply to a regulatory authority to switch the medicine to a non-prescription status.

When reviewing a switch application, regulators evaluate several factors. They consider whether the condition being treated is self-diagnosable—for example, seasonal allergies or mild heartburn. They also review the medicine's potential for misuse or addiction, the severity of potential side effects if taken incorrectly, and whether the consumer can safely understand the label instructions without a doctor's guidance. If the regulator is satisfied that the benefits of easier access outweigh the risks, the medicine is reclassified. This process is designed to empower patients to manage minor, self-limiting ailments while freeing up doctor appointments for more serious conditions.

Why the Same Medicine Has Different Statuses

Because national regulators make independent decisions based on their specific populations, a medicine's classification often varies by country. A well-known example is the painkiller ibuprofen. In many countries, lower doses of ibuprofen are widely available in supermarkets as an OTC medicine. In other jurisdictions, however, it may only be sold in pharmacies under the supervision of a pharmacist, or only in very small pack sizes. Another example is certain emergency contraceptive pills containing levonorgestrel. These are available directly from pharmacy shelves in countries like South Africa and the United Kingdom, but in other nations, they require a doctor's prescription.

These differences arise from varying approaches to risk management. A regulator might restrict a medicine if it interacts heavily with local staple foods, if there are concerns about antimicrobial resistance, or if the country's healthcare system relies heavily on doctor consultations to monitor public health. Cultural attitudes toward self-care also play a significant role. In countries with a strong tradition of community pharmacy, regulators may be more comfortable allowing pharmacists to manage access to certain treatments, leading to different classifications for the same drug.

Behind-the-Counter and the Pharmacist's Role

The choice between OTC and prescription is not always strictly binary. Many countries use an intermediate category, often called "pharmacy-only" or "behind-the-counter" medicines. In these cases, the product is not displayed on open shelves, but it does not require a doctor's prescription. Instead, the consumer must request it directly from the pharmacist. This intermediate step acts as a safety net, ensuring that a healthcare professional is involved in the transaction.

When dispensing a behind-the-counter medicine, the pharmacist acts as a triage point. They will ask brief questions to ensure the medicine is appropriate for the consumer's symptoms, check for allergies or potential interactions with other treatments, and provide advice on how to use it safely. This system allows broader access to treatments—such as stronger pain relievers or certain allergy medications—while maintaining a layer of clinical oversight. In South Africa, the South African Health Products Regulatory Authority (SAHPRA) classifies medicines into various schedules, with Schedule 1 and 2 generally covering pharmacy or over-the-counter items, while higher schedules require prescriptions.

Finding Accurate Medicine Information

Because medicine classifications differ so widely, understanding the status of a specific treatment requires checking local regulatory databases. The World Health Organization (WHO) maintains a list of medicines considered essential for basic health systems, but even this list does not dictate exact OTC or prescription classifications, leaving the final decision to individual nations. When searching for information, it is important to rely on official sources.

For individuals in South Africa, tools like HealthSA can be used to search for medicine prices and registration details. Understanding whether a medicine is OTC or prescription-only is a crucial first step in managing your own healthcare, as it determines how you can legally and safely access the treatment. Always consult a pharmacist or doctor if you are unsure whether a non-prescription medicine is appropriate for your symptoms.